KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Alnylam Pharmaceuticals (ALNY) over the last 17 years, with Q3 2025 value amounting to $188.0 million.

  • Alnylam Pharmaceuticals' Prepaid Assets rose 2936.77% to $188.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.0 million, marking a year-over-year increase of 2936.77%. This contributed to the annual value of $117.0 million for FY2024, which is 745.2% down from last year.
  • As of Q3 2025, Alnylam Pharmaceuticals' Prepaid Assets stood at $188.0 million, which was up 2936.77% from $147.3 million recorded in Q2 2025.
  • Alnylam Pharmaceuticals' 5-year Prepaid Assets high stood at $202.0 million for Q1 2024, and its period low was $76.0 million during Q1 2021.
  • For the 5-year period, Alnylam Pharmaceuticals' Prepaid Assets averaged around $132.9 million, with its median value being $129.8 million (2022).
  • Per our database at Business Quant, Alnylam Pharmaceuticals' Prepaid Assets soared by 6967.15% in 2024 and then plummeted by 2452.96% in 2025.
  • Alnylam Pharmaceuticals' Prepaid Assets (Quarter) stood at $88.1 million in 2021, then surged by 50.91% to $132.9 million in 2022, then fell by 4.92% to $126.4 million in 2023, then dropped by 7.45% to $117.0 million in 2024, then soared by 60.76% to $188.0 million in 2025.
  • Its last three reported values are $188.0 million in Q3 2025, $147.3 million for Q2 2025, and $152.4 million during Q1 2025.